SCHEMBL2937996

SCHEMBL2937996

CSCCC1NC2(CCN(C(=O)C3=COC(Cc4ccccc4)O3)CC2)N(Cc2cccc(C#N)c2)C1=O

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM3 P20309 1/20 0.35
CCR3 P51677 4/20 0.34
FAAH O00519 1/20 0.33
KCNH2 Q12809 2/20 0.33
CCR5 P51681 1/20 0.33
DRD4 P21917 1/20 0.33
MGLL Q99685 1/20 0.33
SIRT2 Q8IXJ6 1/20 0.33
SIRT1 Q96EB6 1/20 0.33
CHRM4 P08173 3/20 0.32
OPRM1 P35372 2/20 0.32
SIGMAR1 Q99720 1/20 0.32
CHRM2 P08172 1/20 0.31
CHRM1 P11229 1/20 0.31
USP2 O75604 1/20 0.31
ALDH1A1 P00352 1/20 0.31
CYP3A4 P08684 1/20 0.31
CYP2C19 P33261 1/20 0.31
CACNA1G O43497 1/20 0.31
OPRL1 P41146 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3925657 0.84 CHRM3 (0.40) CHRM3CCR3FAAHKCNH2DRD4
SCHEMBL3914895 0.82 CHRM3 (0.40) CHRM3CCR3FAAHKCNH2DRD4
SCHEMBL1800614 0.81 RORC (0.40) CHRM3CCR3FAAHDRD4CHRM4
SCHEMBL4040064 0.80 CHRM3 (0.39) CHRM3CCR3FAAHKCNH2DRD4
SCHEMBL1802714 0.80 KMT2A (0.43) USP2ALDH1A1CYP3A4CYP2C19
SCHEMBL4038037 0.80 CHRM3 (0.37) CHRM3CCR3FAAHKCNH2CCR5
SCHEMBL1803360 0.80 HPGD (0.39) CHRM3USP2ALDH1A1CYP3A4CYP2C19
SCHEMBL1799605 0.80 MAPK1 (0.46) CHRM3FAAHUSP2ALDH1A1CYP3A4
SCHEMBL4037652 0.79 CHRM3 (0.41) CHRM3CCR3FAAHDRD4MGLL
SCHEMBL1800488 0.79 HSD11B1 (0.39) CHRM3MGLLCHRM4USP2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1730147-B1 SUBSTITUTED 1,4,8-TRIAZASPIRO[4,5]DECAN-2-ON COMPOUNDS FOR USE IN THE TREATMENT OF OBESITY GRUENENTHAL GMBH (DE) 2010-02-03 EP claimed
EP-1730147-B1 SUBSTITUTED 1,4,8-TRIAZASPIRO[4,5]DECAN-2-ON COMPOUNDS FOR USE IN THE TREATMENT OF OBESITY GRUENENTHAL GMBH (DE) 2010-02-03 EP disclosed
WO-2005095402-A9 SUBSTITUTED 1,4,8-TRIAZASPIRO[4.5]DECAN-2-ON COMPOUNDS FOR USE IN THE TREATMENT OF OBESITY GRUENENTHAL GMBH (DE) 2009-06-11 WO disclosed
EP-1730147-A1 SUBSTITUTED 1,4,8-TRIAZASPIRO[4,5]DECAN-2-ON COMPOUNDS FOR USE IN THE TREATMENT OF OBESITY Grünenthal GmbH (DE) 2006-12-13 EP disclosed
WO-2005095402-A1 SUBSTITUTED 1,4,8-TRIAZASPIRO[4.5]DECAN-2-ON COMPOUNDS FOR USE IN THE TREATMENT OF OBESITY Grünenthal GmbH (DE) 2005-10-13 WO disclosed